Molecular diagnostics company Epigenomics has entered into a €5m convertible bond financing agreement with YA Global Master SPV Ltd. Pursuant to the terms of the agreement, YA Global Master SPV will purchase convertible notes with a ...
Tags: Epigenomics, Molecular diagnostics
Epigenomics has released additional results from the comparative study aimed to know non-inferiority of Epi proColon assay performance in comparison to fecal immunochemical testing (FIT). The additional data had shown that Epi proColon ...
Tags: Epigenomics, additional data, Epi proColon, Medicine
Epigenomics has reported positive results from a clinical study, which showed that its blood-based colorectal cancer (CRC) detection test is non-inferior in sensitivity when compared to fecal immunochemical testing (FIT). Using patients ...
Tags: Epigenomics, blood-based colorectal cancer, non-inferior in sensitivity
Epigenomics has announced results from a comparative study between its blood-based colorectal cancer(CRC)detection test Epi proColon and fecal immunochemical testing(FIT)to demonstrate the non-inferiority of Epi proColon in detection of ...
Tags: Epigenomics, CRC, FIT, Epi proColon